We are live on ! Find out more
KZIA

Kazia Therapeutics
KZIA

12 hedge funds and large institutions have $4.35M invested in Kazia Therapeutics in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

54% more call options, than puts

Call options by funds: $367K | Put options by funds: $239K

0% more funds holding

Funds holding: 12 → 12 (0)

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

6% less capital invested

Capital invested by funds: $4.6M → $4.35M (-$255K)

Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
3
Calls
$367K
Puts
$239K
Net Calls
+$128K
Net Calls Change
+$399K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$453K
2
Citadel Advisors
Citadel Advisors
Florida
+$135K
3
SG Americas Securities
SG Americas Securities
New York
+$50.6K
4
Simplex Trading
Simplex Trading
Illinois
+$48.5K
5
Morgan Stanley
Morgan Stanley
New York
+$33.2K

Top Sellers

Rank Fund Capital Flow
1
SFI
Susquehanna Fundamental Investments
Pennsylvania
-$144K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$105K
3
TCWM
Total Clarity Wealth Management
Illinois
-$22K
4
UBS Group
UBS Group
Switzerland
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$2.31M +$33.2K +63 +1%
Renaissance Technologies
2
Renaissance Technologies
New York
$649K +$453K +859 +188%
SG Americas Securities
3
SG Americas Securities
New York
$438K +$50.6K +96 +12%
Truist Financial
4
Truist Financial
North Carolina
$287K +$10.5K +20 +4%
ACM
5
ACT Capital Management
Pennsylvania
$247K +$263K +500 New
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$141K -$105K -200 -41%
Citadel Advisors
7
Citadel Advisors
Florida
$126K +$135K +256 New
TW
8
Transform Wealth
Colorado
$104K – – –
Simplex Trading
9
Simplex Trading
Illinois
$45K +$48.5K +92 New
Deutsche Bank
10
Deutsche Bank
Germany
$1K – – –
SPIA
11
Steward Partners Investment Advisory
New York
$1K – – –
RE
12
RBC Europe
United Kingdom
$316 – – –
SFI
13
Susquehanna Fundamental Investments
Pennsylvania
– -$144K -232 Closed
TCWM
14
Total Clarity Wealth Management
Illinois
– -$22K -36 Closed
UBS Group
15
UBS Group
Switzerland
– -$20K -32 Closed

KZIA Hedge Fund Activity: Q2 2021 in Review

12 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q2 2021, worth a combined $4.35M — down 5.5% from $4.6M a quarter earlier.

Fund positioning in KZIA was balanced in Q2 2021: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $453K. The largest seller was Susquehanna Fundamental Investments, exiting entirely with an estimated $144K sold.

  • 12 institutional investors held Kazia Therapeutics (KZIA) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $4.35M of Kazia Therapeutics stock for Q2 2021, down 5.5% quarter-over-quarter.
  • 3 funds opened new Kazia Therapeutics positions in Q2 2021 and 3 closed out, a net change of 0 holders.
  • The largest Kazia Therapeutics buyer in Q2 2021 was Renaissance Technologies, an estimated $453K added.
  • The largest Kazia Therapeutics seller in Q2 2021 was Susquehanna Fundamental Investments, an estimated $144K sold.

Based on aggregated 13F filings for Q2 2021.